Human Factors Engineering

Human Factors Engineering (HFE) is critical for medical device safety and regulatory compliance, especially for Class II and III devices, drug-delivery systems, and combination products. Following is a detailed breakdown of the regulatory expectations and functional components of HFE. 

What is Human Factors Engineering? 

Human Factors Engineering (HFE)—also called Usability Engineering (UE)—is the application of knowledge about human behavior, capabilities, and limitations to ensure that devices: 

  • Are safe and effective for intended users, 
  • Minimize use-related risks, and
  • Can be used without unintended harm or user error. 

When a “Good Enough” Design May Not Be Sufficient

Many times, a solid basic design may not completely fulfill the needs of its users. Read about a common Class I device that standards and regulations would typically not require a risk/usability analysis may be insufficient for the needs of its users.

Regulatory Requirements and Guidance 

FDA (U.S.) 

The FDA regulates HFE under 21 CFR 820.30 (Design Controls) and defines it primarily through guidance documents.

Key FDA Guidance

FDA Expectations

Employ a risk-based approach to identify critical tasks. Human factors validation testing must demonstrate that intended users can use the device safely and effectively without prior training (unless training is part of the intended use). 

Documentation

  • HFE/UE report with PMA or 510(k), 
  • Validation testing protocols, results, and rationale for user groups.

Devices with user interfaces (buttons, displays, connectors, software, alarms, etc.) must undergo HFE validation. 

International (Global) 

ISO & IEC Standards

  • ISO 14971: Risk management (HFE is a mitigation tool). 
  • IEC 62366-1: Application of usability engineering to medical devices (widely accepted globally, harmonized in the EU). 
  • IEC/TR 62366-2: Guidance on application of usability engineering.

EU MDR

HFE is addressed under General Safety and Performance Requirements (GSPRs) in Annex I, including: 

  • Minimization of use error, 
  • Device usability under normal and fault conditions, 
  • Consideration of ergonomic features. 

Other regions

  • Health Canada, PMDA (Japan), and NMPA (China) expect similar alignment with IEC 62366-1 and ISO 14971. 

When is an HFE Required? 

Device Type 

HFE Required? 

Notes 

Class I  Rarely  Unless has complex UI 
Class II  Often  Especially for home-use, digital, or drug-delivery devices 
Class III  Always  PMA requires robust HFE/UE documentation 
Combination Products  Always  Especially drug-delivery (pens, pumps, injectors) 
Digital Health Software  Yes  Apps, decision-support tools, UI-dependent devices 

 

What Are Early Recall Alerts?

Recall Communication “Early Alerts” Note: This summary is based on an FDA communication attributed to Michelle Tarver, M.D., Ph.D., director of the Center for Devices and Radiological Health (CDRH). In November 2024 the U.S. Food and Drug Administration’s Center for...

read more

Urgent Recall Alert for BD Alaris Infusion Sets

Class I Recall (Correction) The FDA has issued an early alert to healthcare providers and patients regarding a performance issue affecting BD Alaris Pump Module model 8100, used with specific compatible infusion sets. BD, through its subsidiary CareFusion, has...

read more

Recall Alert: AirLife/Vyaire Infant Breathing Systems

Class I Recall AirLife and manufacturer Vyaire are recalling specific Infant Heated Wire Circuits due to the risk that accessory adapters may disconnect during use, especially once the system reaches operating temperature. This could lead to serious injury or death,...

read more

Key Functional Components of the HFE Process 

Stage 

Description 

Activities 

1. User & Use Environment Analysis  Identify intended users, use scenarios, and use environments  Interviews, surveys, user profiles, task analysis 
2. Hazard Identification (Use Errors)  Identify potential use errors and hazards  Link to risk management (ISO 14971) 
3. Preliminary Usability Testing  Early testing with prototypes  Formative studies, heuristic evaluations 
4. Design Iteration  Refine UI and device based on feedback  UI redesign, labeling adjustments, feedback loops 
5. Validation (Summative Testing)  Demonstrate users can safely use the device  Simulated-use testing (≥15 representative users per group) 
6. Documentation & Submission  Report HFE findings and validation  Submit HFE/UE report with regulatory submission 

Human Factors/Usability Report 

FDA and global reviewers expect a report to contain the following documentation: 

  • Summary of use-related hazards
  • User population analysis
  • Use environment details
  • Critical task identification
  • Formative test results
  • Final validation protocol & results
  • Labeling/instructions of use impact

Critical Tasks = tasks that, if performed incorrectly or not performed at all, could result in serious harm to the user or patient. 

HFE Validation Testing Best Practices 

  • Conduct in a realistic simulated-use environment 
  • Use representative users (e.g., patients, caregivers, clinicians) 
  • No training immediately before testing unless training is part of actual use 
  • Collect both success/failure and behavioral data (e.g., hesitations, workarounds) 
  • Capture root cause analysis for any errors or difficulties